Zurich, Switzerland, and Whitehouse Station, N.J, April 26, 2010 – Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced ......

Great Place to Work® Institute Canada Ranks Nycomed as top pharmaceutical employer ...

Lancet Canadian Press Release ...

Nycomed's Instanyl® receives positive CHMP opinion, bringing forward a new treatment for breakthrough cancer pain ...

Press Release Distribution Agreement for Pollinex® R in Canada Exclusive Negotiation Period for Pollinex Quattro in Canada ...

Great Place to Work® Institute Canada Ranks Nycomed as top pharmaceutical employer OAKVILLE, ON – April 6, 2009 – For the second year in a row, pharmaceutical company Nycomed Canada Inc......

~ Health Canada approves new generation asthma medication to help children manage their disease ~ Oakville, ON - February 11, 2009 – Canadian parents of children with asthma may be lacking a sense of urgency and concern about the severity and management of their child’s disease, resulting in potential health risks to their children......

Nycomed is recognised for providing exceptional workplace for employees OAKVILLE , ON – October 2, 2008 – Today, Nycomed Canada has been recognised as Top 100 Employer in Canada......

Press Release Nycomed successfully closes oncology program Preclinical anti-cancer program sold to Bayer Schering Pharma Bayer Schering Pharma will assume full development and commercialization rights Nycomed agreed with Bayer Schering Pharma on the sale of the preclinical anti-cancer program......

~ Company signs licensing agreement with Chiesi Farmaceutici SpA to market Atimos® for asthma and COPD ~ Oakville, Ontario – June 25, 2008 - Nycomed Canada Inc. today announced a licensing agreement with Chiesi Farmaceutici SpA to market Atimos® (formoterol), a treatment anticipated to be indicated for asthma and Chronic Obstructive Pulmonary Disease (COPD)......